Identification of a novel antifungal nonapeptide generated by combinatorial approach

被引:15
作者
Kumar, M [1 ]
Chaturvedi, AK [1 ]
Kavishwar, A [1 ]
Shukla, PK [1 ]
Kesarwani, AP [1 ]
Kundu, B [1 ]
机构
[1] Cent Drug Res Inst, Div Med Mycol, Lucknow 226001, Uttar Pradesh, India
关键词
combinatorial chemistry; nonapeptide; antifungal activity; synergy;
D O I
10.1016/j.ijantimicag.2004.10.015
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
It is becoming clear that antimicrobial peptides are important components of the innate defences of all species of life. They kill very rapidly, do not easily select resistant mutants and are synergistic with potentially toxic conventional therapeutic agents against microbes. This paper describes an attempt to expand a lead hexapeptide motif synthesized through combinatorial approach. A cationic peptide H-Arg-Ti-p-Trp-Arg-D-Ti-p-D-Phe-lie-D-Plie-His-NH2 was found to be active with a therapeutic index of >17.1 was proposed that the combination of peptide with known antifungal agents may identify synergistic combinations that would ideally reduce the dosage of conventional antifungals as well as their associated toxicity. Nine different pathogenic strains and species of Candida and two of Cryptococcus neoformans were eiriployed in chequerboard method and in time kill assays to evaluate the synergistic effect of the lead peptide in combination with amphotericin B., 5-flucytosine. ketoconazole and fluconazole. We found synergistic interaction between the peptide and all four drugs against Cryptococcus isolates whilst both synergistic and additive combinations occurred when Candida isolates were used. (C) 2005 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 26 条
[1]   Interactions between triazoles and amphotericin B against Cryptococcus neoformans [J].
Barchiesi, F ;
Schimizzi, AM ;
Caselli, F ;
Novelli, A ;
Fallani, S ;
Giannini, D ;
Arzeni, D ;
Di Cesare, S ;
Di Francesco, LF ;
Fortuna, M ;
Giacometti, A ;
Carle, F ;
Mazzei, T ;
Scalise, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2435-2441
[2]   METHOD FOR TESTING FOR SYNERGY WITH ANY NUMBER OF AGENTS [J].
BERENBAUM, MC .
JOURNAL OF INFECTIOUS DISEASES, 1978, 137 (02) :122-130
[3]   ANTIFUNGAL ACTION OF AMPHOTERICIN-B IN COMBINATION WITH OTHER POLYENE OR IMIDAZOLE ANTIBIOTICS [J].
BRAJTBURG, J ;
KOBAYASHI, D ;
MEDOFF, G ;
KOBAYASHI, GS .
JOURNAL OF INFECTIOUS DISEASES, 1982, 146 (02) :138-146
[4]   In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach [J].
Dorsthorst, DTAT ;
Verweij, PE ;
Meletiadis, J ;
Bergervoet, M ;
Punt, NC ;
Meis, JFGM ;
Mouton, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) :2982-2989
[5]   Antibacterial agents based on the cyclic D,L-α-peptide architecture [J].
Fernandez-Lopez, S ;
Kim, HS ;
Choi, EC ;
Delgado, M ;
Granja, JR ;
Khasanov, A ;
Kraehenbuehl, K ;
Long, G ;
Weinberger, DA ;
Wilcoxen, KM ;
Ghadiri, MR .
NATURE, 2001, 412 (6845) :452-455
[6]   Emerging novel antifungal agents [J].
Fostel, JM ;
Lartey, PA .
DRUG DISCOVERY TODAY, 2000, 5 (01) :25-32
[7]   The role of antimicrobial peptides in animal defenses [J].
Hancock, REW ;
Scott, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :8856-8861
[8]   Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides [J].
Helmerhorst, EJ ;
Reijnders, IM ;
van't Hof, W ;
Simoons-Smit, I ;
Veerman, ECI ;
Amerongen, AVN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (03) :702-704
[9]  
JUNG G, 1996, COMBINATORIAL PEPTID
[10]  
KLESPER ME, 1998, ANTIMICROB AGENTS CH, V42, P1207